Are All Peptides Proven to Work?

You might have heard that peptides are the ultimate health shortcut. It sounds great, right? But if we look at the actual data, the truth is a bit more like a messy group project where some people did all the work and others are just hanging out in the back.

Scientists are still working on this one — turns out the human body is complicated. Who knew?

The A-Plus Students

Some peptides have been through the wringer and come out with high marks. These are the ones your doctor likely knows about because the FDA has actually given them the thumbs up.

• Semaglutide [Grade: A+]: This one mimics a natural hormone called GLP-1. In a major study called STEP 1, people saw a 14.9% weight loss. It is FDA-approved under names like Wegovy and Ozempic, but it does have downsides, like nausea in about 44% of people.
• Tirzepatide [Grade: A+]: This is a dual agonist, meaning it hits two different hormone receptors at once. It showed even higher weight loss at 22.5% in the SURMOUNT-1 trial and is FDA-approved as Zepbound and Mounjaro.
• Tesamorelin [Grade: A]: This targets visceral adipose tissue, which is just a fancy way of saying belly fat around your organs. While it is FDA-approved, it is only for a specific condition called HIV-associated lipodystrophy. If you stop taking it, the effects completely reverse.

The 'Almost' Crowd

Then there are the peptides that are popular in other countries but haven't quite convinced the US regulators yet. It is a bit like a movie that is a huge hit in Europe but never makes it to your local theater.

Thymosin Alpha-1 [Grade: A-] has been studied in over 1,000 patients for hepatitis and is approved in more than 35 countries. However, it is not FDA-approved here in the states, and its use for anti-aging doesn't have a set dose yet.

Semax [Grade: B] has been used in Russia for stroke recovery since the 1990s. While it has 25 years of history there, it has very limited validation in Western studies and no FDA approval.

The One That Isn't Even a Peptide

Sometimes, things get lumped into the peptide category that don't actually belong there. Take MK-677 [Grade: B]. Technically, it is a small-molecule ghrelin mimetic, not a peptide. It did help people gain about 1.1kg of fat-free mass in a two-year study, but it also raised fasting glucose levels. It even failed a trial for Alzheimer's.

What We Don't Know Yet

Even the "proven" ones have gaps. For example, weight regain after stopping Semaglutide is substantial. We also don't have the long-term heart health data for Tirzepatide yet, as those trials are still ongoing.

This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.

---

This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.